1784Accesses
Abstract
A 41-year-old man presented initially for the evaluation and management of a thyroid nodule, which was noted incidentally on imaging. Further evaluation revealed the presence of a papillary thyroid carcinoma. A total thyroidectomy was performed and he immediately started taking levothyroxine as the standard replacement therapy. Based on his stage of cancer, TSH suppression was not required and therefore the TSH goal was to remain within the normal reference range. The initial dose was calculated based on his weight, and he started taking 150 μg of levothyroxine daily.
This is a preview of subscription content,log in via an institution to check access.
Access this chapter
Subscribe and save
- Get 10 units per month
- Download Article/Chapter or eBook
- 1 Unit = 1 Article or 1 Chapter
- Cancel anytime
Buy Now
- Chapter
- JPY 3498
- Price includes VAT (Japan)
- eBook
- JPY 12583
- Price includes VAT (Japan)
- Softcover Book
- JPY 15729
- Price includes VAT (Japan)
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Escobar-Morreale HF, Botella-Carretero JI, Escobar del Rey F, Morreale de Escobar G. REVIEW: treatment of hypothyroidism with combinations of levothyroxine plus liothyronine. JCEM. 2005;90(8):4946–54.
Grozinsky-Glasberg S, Fraser A, Nahshoni E, Weizman A, Leibovici L. Thyroxine-triiodothyronine combination therapy versus thyroxinemonotherapy for clinical hypothyroidism: meta-analysis of randomized controlled trials. JCEM. 2006;91(7):2592–9.
Saravanan P, Simmons D, Greenwood R, Peters TJ, Dayan CM. Partial substitution of thyroxine (T4) with tri-iodothyronine in patients on T4 replacement therapy: results of a large community-based randomized controlled trial. JCEM. 2005;90(2):805–12.
Panicker V, Saravana P, Vaidya B, Evans J, Hattersley AT, Frayling TM, Dayan CM. Common variation in the DIO2 gene predicts baseline psychological well-being and response to combination thyroxine plus triiodothyronine therapy in hypothyroid patients. JCEM. 2009;94(5):1623–9.
Garber JR, Cobin RH, Gharib H, Hennessey JV, Klein I, Mechanick JI, Pessah-Pollack R, Singer PA, Woeber KA, American Association of Clinical Endocrinologists and American Thyroid Association Taskforce on Hypothyroidism in Adults. Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Endocr Pract. 2012;18(6):988–1028.
Author information
Authors and Affiliations
Thyroid Unit, Massachusetts General Hospital, Harvard Medical School, 15 Parkman Street, WAC 7-730S, Boston, MA, 02114, USA
Joy Tsai M.D. & Nikolaos Stathatos M.D.
- Joy Tsai M.D.
Search author on:PubMed Google Scholar
- Nikolaos Stathatos M.D.
Search author on:PubMed Google Scholar
Corresponding author
Correspondence toNikolaos Stathatos M.D..
Editor information
Editors and Affiliations
Div. Endocrinology, Diabetes & Bone Disease, Mount Sinai School of Medicine Dept. Medicine, New York, New York, USA
Terry F. Davies
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media New York
About this chapter
Cite this chapter
Tsai, J., Stathatos, N. (2015). Treatment of Hypothyroidism: Utility of Adding T3 (Liothyronine). In: Davies, T. (eds) A Case-Based Guide to Clinical Endocrinology. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-2059-4_11
Download citation
Publisher Name:Springer, New York, NY
Print ISBN:978-1-4939-2058-7
Online ISBN:978-1-4939-2059-4
eBook Packages:MedicineMedicine (R0)
Share this chapter
Anyone you share the following link with will be able to read this content:
Sorry, a shareable link is not currently available for this article.
Provided by the Springer Nature SharedIt content-sharing initiative